Vivani Medical, Inc. Foreign Currency Transaction Gain (Loss), Realized
Vivani Medical, Inc. (VANI) reported Foreign Currency Transaction Gain (Loss), Realized of $45.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2018-05-15
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for the quarter ending 2018-03-31 was $45.00K, a 50.00% increase year-over-year.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for the quarter ending 2017-12-31 was $0.00.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for the quarter ending 2017-09-30 was -$86.00K, a 352.94% decline year-over-year.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for the quarter ending 2017-06-30 was $92.00K.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for fiscal 2017 was $36.00K.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for fiscal 2016 was -$27.00K.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for fiscal 2015 was -$107.00K.
- Vivani Medical, Inc. foreign currency transaction gain (loss), realized for fiscal 2014 was -$207.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2018-03-31 | $45.00K 10-Q · filed 2018-05-15 | $45.00K derived: sum of 2 quarters · filed 2018-05-15 | -$41.00K derived: sum of 3 quarters · filed 2018-05-15 | $51.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$86.00K derived: sum of 2 quarters · filed 2018-03-20 | $6.00K derived: sum of 3 quarters · filed 2018-03-20 | $36.00K 10-K · filed 2018-03-20 |
| 2017-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $6.00K derived: sum of 2 quarters · filed 2017-11-06 | $36.00K 10-Q · filed 2017-11-06 | -$48.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $122.00K 10-Q · filed 2017-08-07 | $38.00K derived: sum of 3 quarters · filed 2018-05-15 | $72.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-03-31 | $30.00K 10-Q · filed 2018-05-15 | -$54.00K derived: sum of 2 quarters · filed 2018-05-15 | -$20.00K derived: sum of 3 quarters · filed 2018-05-15 | -$50.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$50.00K derived: sum of 2 quarters · filed 2018-03-20 | -$80.00K derived: sum of 3 quarters · filed 2018-03-20 | -$27.00K 10-K · filed 2018-03-20 |
| 2016-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $4.00K derived: sum of 2 quarters · filed 2017-11-06 | $57.00K 10-Q · filed 2017-11-06 | |
| 2016-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $23.00K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $53.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | -$107.00K 10-K · filed 2018-03-20 | |||
| 2014-12-31 | -$207.00K 10-K · filed 2017-03-16 | |||
| 2013-12-31 | -$82.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |